Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

COVID-19 may cause hair loss by affecting hair follicles.

Mutations in the spike protein affect drug binding and effectiveness.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

COVID-19 can cause hair loss and nail issues, with treatments available for these conditions.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

COVID-19 may worsen Parkinson's disease by affecting certain brain proteins.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Continued vaccine and drug development is crucial due to new virus variants and regional infection spikes.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Natural products like flavonoids and phenolics may help treat or prevent COVID-19.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 may harm male fertility and damage the reproductive system.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.